Leaderboards/Infectious Diseases and Mycology

Infectious Diseases and Mycology

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Natália Nosálová
University of Pavol Jozef Šafárik
2
Noémie Dupouy-Manescau
Oniris
3
Dereje A. Negatu
AIDS Clinical Trials Group
4
Dan-Dan Zou
First People's Hospital of Yunnan Province
5
Uday S. Ganapathy
Hackensack Meridian Health
6
Mia Niva
Unknown
7
Binayak Rimal
Johns Hopkins University
8
Burair Alsaihati
King Abdulaziz City for Science and Technology
9
Wenting Xie
Chinese Academy of Medical Sciences & Peking Union Medical College
10
Hui-Hua Zheng
Zhejiang A & F University

Papers

1
Canine Mammary Tumors: Classification, Biomarkers, Traditional and Personalized Therapies
International Journal of Molecular Sciences|2024
51 cit.
2
Publication in Animals (2024) [44 citations, W4391994363]
Animals|2024
44 cit.
3
Publication in British Journal of Dermatology (2024) [28 citations, W4390615884]
British Journal of Dermatology|2024
28 cit.
4
Actinobacterial communities of boreal forest soil and lake water are rich in mycobacteria
Boreal Environment Research Journal Archive|2024
26 cit.
5
Publication in ACS Omega (2024) [17 citations, W4401898636]
ACS Omega|2024
17 cit.
6
Publication in Emerging Microbes & Infections (2025) [12 citations, W4409887162]
Emerging Microbes & Infections|2025
12 cit.
7
Publication in Tuberculosis (2024) [11 citations, W4391678552]
Tuberculosis|2024
11 cit.
8
Publication in Antimicrobial Agents and Chemotherapy (2024) [10 citations, W4400734726]
Antimicrobial Agents and Chemotherapy|2024
10 cit.
9
Publication in Antimicrobial Agents and Chemotherapy (2025) [9 citations, W4408450341]
Antimicrobial Agents and Chemotherapy|2025
9 cit.
10
Durlobactam to boost the clinical utility of standard of care β-lactams against <i>Mycobacterium abscessus</i> lung disease
Antimicrobial Agents and Chemotherapy|2024
7 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Jeen Son
McMaster University
2
Nalin N. Wijayawardene
Mae Fah Luang University
3
Binghuai Lu
Chinese Academy of Medical Sciences & Peking Union Medical College
4
Karen Yumi Ribeiro Nakagaki
Universidade Federal de Minas Gerais
5
Emily A. Merkel
Johns Hopkins University
6
Bin Zhang
Northwestern University
7
Mari Pires de Oliveira Kelly
Universidade Federal da Grande Dourados
8
Jie Huang
Sichuan Agricultural University
9
Juliana Siqueira Argenta
Total (France)
10
Christina Y. Lee
Memorial Sloan Kettering Cancer Center

Papers

1
Epidemiology and Antimicrobial Resistance Profiles of the <i>Nocardia</i> Species in China, 2009 to 2021
Microbiology Spectrum|2022
96 cit.
2
Forecasting the number of species of asexually reproducing fungi (Ascomycota and Basidiomycota)
Fungal Diversity|2022
50 cit.
3
Classes and phyla of the kingdom Fungi
Fungal Diversity|2024
50 cit.
4
Tracking international and regional dissemination of the KPC/NDM co-producing Klebsiella pneumoniae
Nature Communications|2025
24 cit.
5
Genetic Diversity of Polymyxin-Resistance Mechanisms in Clinical Isolates of Carbapenem-Resistant Klebsiella pneumoniae: a Multicenter Study in China
Microbiology Spectrum|2023
21 cit.
6
Two outbreak cases involving ST65-KL2 and ST11-KL64 hypervirulent carbapenem-resistant Klebsiella pneumoniae: similarity and diversity analysis
Communications Biology|2024
19 cit.
7
Integrating DNA and RNA sequencing for enhanced pathogen detection in respiratory infections
Journal of Translational Medicine|2025
18 cit.
8
Carbapenem-resistant Citrobacter freundii harboring blaKPC−2 and blaNDM−1: a study on their transferability and potential dissemination via generating a transferrable hybrid plasmid mediated by IS6100
Frontiers in Microbiology|2023
16 cit.
9
In-host intra- and inter-species transfer of blaKPC-2 and blaNDM-1 in Serratia marcescens and its local and global epidemiology
International Journal of Antimicrobial Agents|2024
15 cit.
10
Fungi associated with dead branches of Magnolia grandiflora: A case study from Qujing, China
Frontiers in Microbiology|2022
14 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Richard J. Wallace
The University of Texas at Tyler
2
Thomas F. Patterson
National Institute of Allergy and Infectious Diseases
3
Kevin Winthrop
Oregon Health & Science University
4
Thomas J. Walsh
Cornell University
5
David W. Denning
Manchester Academic Health Science Centre
6
Paul E. Verweij
Radboud University Nijmegen
7
Oliver A. Cornely
Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases
8
Michel Drancourt
Aix-Marseille Université
9
Charis Eng
Cleveland Clinic
10
Milind Rajadhyaksha
Memorial Sloan Kettering Cancer Center

Papers

1
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
Clinical Infectious Diseases|2016
2.8k cit.
2
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
Clinical Infectious Diseases|2008
2.7k cit.
3
Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus
Clinical Infectious Diseases|2002
2.3k cit.
4
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
New England Journal of Medicine|2007
1.8k cit.
5
Confocal Imaging–Guided Laser Ablation of Basal Cell Carcinomas: An Ex Vivo Study
Journal of Investigative Dermatology|2014
1.7k cit.
6
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
Clinical Microbiology and Infection|2018
1.5k cit.
7
Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus
Nature|2005
1.4k cit.
8
Germ-Line Mutations in Nonsyndromic Pheochromocytoma
New England Journal of Medicine|2002
1.4k cit.
9
Global incidence and mortality of severe fungal disease
The Lancet Infectious Diseases|2024
1.3k cit.
10
ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients
Clinical Microbiology and Infection|2012
1.2k cit.

Reagents for Infectious Diseases and Mycology

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 61

PathScan® Phospho-ALK (Tyr1604) Sandwich ELISA Kit

#7324$66,129,740
View Evidence →
Cell Signaling Technology

CREB Control Cell Extracts

#9193$165
View Evidence →
Cell Signaling TechnologyEvidence 66

Neurofilament-L (DA2) Mouse Monoclonal Antibody

#2835$147,345
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 66

Phospho-PAK1 (Ser144)/PAK2 (Ser141) Antibody

#2606$152,362
View Evidence →
Cell Signaling TechnologyEvidence 62

Phospho-beta-Catenin (Ser552) Antibody

#9566$362
View Evidence →
Cell Signaling Technology

DCLK1/DCAMKL1 (D2U3L) Rabbit Monoclonal Antibody (BSA and Azide Free)

#10208$865
View Evidence →